Dacarbazin

Description

Indications for the drug Dacarbazin:

Melanoma, lymphogranulomatosis, soft tissue sarcoma (excluding Kaposi’s sarcoma).

As part of multicomponent chemotherapy regimens: osteogenic sarcoma, uterine sarcoma, lymphosarcoma, embryonal rhabdomyosarcoma, pleural and peritoneal mesothelioma, small cell lung cancer, thyroid cancer, carcinoid, pheochromocytoma, insulinoma, neuroblastoma, glioma.

Active ingredient: dacarbazine citrate

Prescription medicine